Skip to content
  • 713-358-6500
  • Home
  • RAHA-100
  • About us
    • Management Team
  • Press Releases
  • Media
  • Manufacturing
  • Our Pipeline
  • Careers
  • Contact Us
  • Home
  • RAHA-100
  • About us
    • Management Team
  • Press Releases
  • Media
  • Manufacturing
  • Our Pipeline
  • Careers
  • Contact Us

Media

Playlist

7 Videos
Innovating On The Frontier Of Radiopharmaceuticals With RadioMedix's Ebrahim Delpassand, M.D.

54:08
Radiopharmaceuticals and the Future of Nuclear Medicine with RadioMedix CEO Dr. Ebrahim Delpassand

37:36
Who We Are

5:09
Manufacturing

1:10
RadioMedix Highlight

4:09
Company Culture

1:17
CEO, Dr D

1:10

In The News

  • Radiopharma’s big year: Interview with RadioMedix CEO Dr. Delpassand
  • Former MD Anderson researcher unveils tech to 'democratize' access to cancer research
  • Harnessing the Power of Alpha-Emitters for Precision Cancer Therapy with Dr. Delpassand RadioMedix
  • From Isotope to Impact: How Radiopharmaceuticals Are Changing Cancer Care
  • Why Radiopharmaceuticals are Gaining Ground in the Fight Against Cancer
  • Peeling Back The Layers Of Radiolabeled Peptide Production
  • Houston's Life Sciences Ecosystem Gains Momentum with Support from RadioMedix and Others
Copyright © 2025 RadioMedix, Inc. is a clinical stage biotechnology company, based in Houston, Texas. | Powered by RadioMedix
Facebook Youtube X-twitter Linkedin
Quick Link
  • Home
  • About Us
  • Press Releases
  • Careers
  • Manufacturing
  • Pipeline
  • Contact Us
Contact Info
  • RadioMedix 9701 Richmond Avenue, Suite 222 Houston, Texas 77042
  • Phone:+1 713-358-6500
  • Fax:+1 713- 588-8937
  • info@radiomedix.com
  • RadioMedix Spica Center 19705 Aldine Westfield Rd Humble, TX 77338
  • Phone: +1 713-358-6500
  • Sales@radiomedix.com